Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
101
-
102
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>H</b>) DHPG did not affect the paired-pulse ratios of GlyR-IPSCs (<i>n</i> = 10). The underlying data for this figure can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000371#pbio.3000371.s001" target="_blank">S1 Data</a>. …”
-
103
Good things come to those who wait—Decreasing impatience for health gains and losses
Published 2020“…As in earlier work, we observe large heterogeneity in time consistency; i.e., a mix of decreasing, increasing and constant (im)patience. …”
-
104
-
105
Decreased <i>CLU</i> expression in VWD ECFCs and in Low-VWF expressing ECs.
Published 2024“…<p><i>CLU</i> expression from control ECs and VWD ECFCs demonstrates decreased <i>CLU</i> expression in VWD ECFCs as compared to control ECs (1A). …”
-
106
Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study
Published 2020“…Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”
-
107
-
108
-
109
-
110
-
111
-
112
-
113
Performance of selected antimalarials against field isolates during the study period.
Published 2024Subjects: -
114
-
115
-
116
-
117
Performance of selected drugs against field isolates during the study period.
Published 2024Subjects: -
118
<i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period.
Published 2024Subjects: -
119
-
120
Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period.
Published 2024Subjects: